reports
Tactile Medical Announces CEO Transition and Preliminary First Quarter...
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue CEO Dan Reuvers to retire; Healthcare veteran and board director Sheri Dodd appointed as Chief Executive OfficerPreliminary, unaudited total revenue for first quarter of 2024 expected to be approximately $61 millionManagement to host conference call on May 6, 2024 to discuss first quarter 2024 financial results MINNEAPOLIS, April 23, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people wit...
Tactile Medical to Release First Quarter of Fiscal Year 2024 Financial...
Tactile Medical to Release First Quarter of Fiscal Year 2024 Financial Results on May 6, 2024 MINNEAPOLIS, April 15, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2024 financial results will be released after the market closes on Monday, May 6, 2024. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on May 6, 2024, to discuss the results of the ...
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year ...
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Outlook Full Year Revenue Increased 11% Year-Over-Year; Full Year Net Income Increased 260%; Full Year Adjusted EBITDA Increased 62% MINNEAPOLIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, 2023. ...
Tactile Medical to Participate in Upcoming Investor Conferences in Feb...
Tactile Medical to Participate in Upcoming Investor Conferences in February and March MINNEAPOLIS, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences: The BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference at the Cliff Lodge in Snowbird, UT. Management will participate in investor meetings on Tuesday, February 13th. There wil...
Tactile Medical to Release Fourth Quarter and Fiscal Year 2023 Financi...
Tactile Medical to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 20, 2024 MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2023 financial results will be released before the market opens on Tuesday, February 20th. Management will host a conference call with a question and answer session at 8:00 a.m. Eastern Time on February 20th to discuss the re...
Tactile Systems Technology, Inc. Reports Third Quarter 2023 Financial ...
Tactile Systems Technology, Inc. Reports Third Quarter 2023 Financial Results; Updates Full Year 2023 Outlook MINNEAPOLIS, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Summary: Revenue increased 7% year-over-year to $69.6 million, compared to $65.3 million in third quarter 2022 Lymphedema revenue increased 15%Airway clearance revenue ...
Tactile Medical to Release Third Quarter of Fiscal Year 2023 Financial...
Tactile Medical to Release Third Quarter of Fiscal Year 2023 Financial Results on November 6, 2023 MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2023 financial results will be released after the market closes on Monday, November 6. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on November 6 to discuss the results of the...
Tactile Medical Appoints Vindell Washington, M.D. to Board of Director...
Tactile Medical Appoints Vindell Washington, M.D. to Board of Directors MINNEAPOLIS, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Vindell Washington, M.D. to the Company’s Board of Directors (“Board”), effective October 2, 2023. “We are pleased to welcome Dr. Washington to Tactile Medical, who joins our Board with over 30 years of experience in the healthcare industry,” said Bill Burke, Chairman of the Board of Ta...
Tactile Medical to Participate in Two Upcoming Conferences in Septembe...
Tactile Medical to Participate in Two Upcoming Conferences in September MINNEAPOLIS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences: The Morgan Stanley 21st Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square in New York, NY from September 11th-13th. Management will participate in investor...
Tactile Medical to Present at the 2023 Wells Fargo Healthcare Conferen...
Tactile Medical to Present at the 2023 Wells Fargo Healthcare Conference MINNEAPOLIS, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the 2023 Wells Fargo Healthcare Conference, which is being held at the Encore Boston Harbor in Boston, MA from September 6th - 8th. Management will participate in a fireside chat on Thursday, September 7th at 8:45 a.m. Eastern Time. A live audio webcast ...
Tactile Systems Technology, Inc. Reports Second Quarter 2023 Financial...
Tactile Systems Technology, Inc. Reports Second Quarter 2023 Financial Results; Updates Full Year 2023 Outlook MINNEAPOLIS, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights: Revenue increased 15% year-over-year to $68.3M Lymphedema revenue increased 16%Airway Clearance revenue increased 4% Operating income of $2.1M, compared...
Tactile Medical Appoints Sherri Ferstler as Senior Vice President of S...
Tactile Medical Appoints Sherri Ferstler as Senior Vice President of Sales MINNEAPOLIS, July 18, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Sherri Ferstler to the position of Senior Vice President of Sales, effective July 31, 2023. Ms. Ferstler will succeed Eric Pauls, who will be resigning from the Company, effective July 28, 2023. “Sherri is a strategic leader with over 25 years of experience in the healthcare industry...
Tactile Medical to Release Second Quarter of Fiscal Year 2023 Financia...
Tactile Medical to Release Second Quarter of Fiscal Year 2023 Financial Results on August 7, 2023 MINNEAPOLIS, June 29, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2023 financial results will be released after the market closes on Monday, August 7. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on August 7 to discuss the results of the qua...
Tactile Medical to Present at the William Blair 43rd Annual Growth Sto...
Tactile Medical to Present at the William Blair 43rd Annual Growth Stock Conference MINNEAPOLIS, May 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 43rd Annual Growth Stock Conference, which is being held at the Loews Chicago Hotel in Chicago, IL from June 6th – 8th. Management will host a presentation with investors on Tuesday, June 6th at 8:00 a.m. Central Time. A live audio webcast o...
Tactile Systems Technology, Inc. Reports First Quarter 2023 Financial ...
Tactile Systems Technology, Inc. Reports First Quarter 2023 Financial Results; Raises Full Year 2023 Outlook First Quarter Revenue Increased 23% Year-Over-Year MINNEAPOLIS, May 08, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2023. First Quarter 2023 Summary: Total revenue increased 23% year-over-year to $58.8 million Lymphedema products revenue increased 22% year-over-...
Tactile Medical to Release First Quarter of Fiscal Year 2023 Financial...
Tactile Medical to Release First Quarter of Fiscal Year 2023 Financial Results on May 8, 2023 MINNEAPOLIS, March 30, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2023 financial results will be released after the market opens on Monday, May 8. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on May 8 to discuss the results of the quarter. Those...
Tactile Medical Appoints Elaine Birkemeyer as Chief Financial Officer
Tactile Medical Appoints Elaine Birkemeyer as Chief Financial Officer MINNEAPOLIS, March 14, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Ms. Birkemeyer will succeed Brent Moen, who is retiring. “Elaine is a dynamic and purpose-driven leader with over 25 years of experience in finance, accounting, and business strateg...
Tactile Medical to Present at Two Upcoming Conferences in March
Tactile Medical to Present at Two Upcoming Conferences in March MINNEAPOLIS, March 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences: The 33rd Oppenheimer Annual Healthcare Conference, which is being held virtually from March 13th-15th. Management will participate in a virtual fireside chat on Monday, March 13th at 12:40 p.m. Eastern Time. The Sidoti Small-Cap C...
Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Pu...
Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $13.00 per share. The gross proceeds to Tactile Medical from the offering, before deducting the underwriting discou...
Tactile Systems Technology, Inc. Announces Proposed Public Offering of...
Tactile Systems Technology, Inc. Announces Proposed Public Offering of Common Stock MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Tactile Medical intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the off...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.